These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12034788)

  • 1. Hyperdense MCA resolved after tPA.
    Tsao JW; Gean AD; Glenn OA; Bonovich DC
    Neurology; 2002 May; 58(10):1512. PubMed ID: 12034788
    [No Abstract]   [Full Text] [Related]  

  • 2. Disappearance of the hyperdense MCA sign after thrombolysis: is it a predictor of better prognosis in patients with acute ischaemic stroke?
    Shuaib A
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):248. PubMed ID: 19228669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperdense carotid T in stroke: 'tree sign'].
    Santos-García D; Núñez-Arias D; Porta-Vila AM; de la Fuente-Fernández R
    Rev Neurol; 2013 Aug; 57(3):134-5. PubMed ID: 23881618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of length of hyperdense MCA sign in acute ischemic stroke predicts disappearance after IV tPA.
    Shobha N; Bal S; Boyko M; Kroshus E; Menon BK; Bhatia R; Sohn SI; Kumarpillai G; Kosior J; Hill MD; Demchuk AM
    J Neuroimaging; 2014; 24(1):7-10. PubMed ID: 23316960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recanalization of Chronic Occlusion of the Middle Cerebral Artery With Tissue Plasminogen Activator Treatment: A Case Report.
    Lee SJ; Cheong JS; Ryu HU; Kang HG
    Clin Neuropharmacol; 2018; 41(4):145-147. PubMed ID: 29787393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of admission hyperglycemia on stroke outcome in reperfused tissue plasminogen activator--treated patients.
    Alvarez-Sabín J; Molina CA; Montaner J; Arenillas JF; Huertas R; Ribo M; Codina A; Quintana M
    Stroke; 2003 May; 34(5):1235-41. PubMed ID: 12677014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential pattern of tissue plasminogen activator-induced proximal middle cerebral artery recanalization among stroke subtypes.
    Molina CA; Montaner J; Arenillas JF; Ribo M; Rubiera M; Alvarez-Sabín J
    Stroke; 2004 Feb; 35(2):486-90. PubMed ID: 14707233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clot characteristics on computed tomography and response to thrombolysis in acute middle cerebral artery stroke.
    Topcuoglu MA; Arsava EM; Akpinar E
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1363-72. PubMed ID: 25804568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.
    Kharitonova T; Thorén M; Ahmed N; Wardlaw JM; von Kummer R; Thomassen L; Wahlgren N;
    J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):273-8. PubMed ID: 18931005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A left MCA territory infarction during intravenous recombinant tissue plasminogen activator therapy for right MCA territory ischaemic stroke.
    Lai CC; Hu CJ
    Emerg Med J; 2006 Feb; 23(2):e11. PubMed ID: 16439725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolysis with alteplase in a pregnant woman with stroke.
    Dapprich M; Boessenecker W
    Cerebrovasc Dis; 2002; 13(4):290. PubMed ID: 12011557
    [No Abstract]   [Full Text] [Related]  

  • 12. A 77-Year-Old Man With Large Vessel Acute Ischemic Stroke.
    Latimer A; Bell J; Powell E; Tilney PV
    Air Med J; 2015; 34(5):230-4. PubMed ID: 26354295
    [No Abstract]   [Full Text] [Related]  

  • 13. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator.
    Molina CA; Alexandrov AV; Demchuk AM; Saqqur M; Uchino K; Alvarez-Sabín J;
    Stroke; 2004 Jan; 35(1):151-6. PubMed ID: 14671245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients.
    Smadja D; Chausson N; Joux J; Saint-Vil M; Signaté A; Edimonana M; Jeannin S; Bartoli B; Aveillan M; Cabre P; Olindo S
    Stroke; 2011 Jun; 42(6):1644-7. PubMed ID: 21527758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A first trimester pregnancy with cerebrovascular accident treated with thrombolytic therapy.
    Bridwell RE; Werbin AJ; Birdsong S; Goss S; Long B
    Am J Emerg Med; 2021 Oct; 48():376.e3-376.e5. PubMed ID: 33863562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-arterial prourokinase for acute ischemic stroke.
    Akins PT
    JAMA; 2000 Apr; 283(16):2102; author reply 2103-4. PubMed ID: 10791495
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
    Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
    Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl.
    Golomb MR; Rafay M; Armstrong D; Massicotte P; Curtis R; Hune S; deVeber GA
    J Child Neurol; 2003 Jun; 18(6):420-3. PubMed ID: 12886978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Carotid Intramural Thrombus With TPA.
    Bennett A; Wold J; de Havenon A
    JAMA Neurol; 2016 Dec; 73(12):1496. PubMed ID: 27802501
    [No Abstract]   [Full Text] [Related]  

  • 20. Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis.
    Ribo M; Molina CA; Alvarez B; Rubiera M; Alvarez-Sabin J; Matas M
    J Neuroimaging; 2010 Jul; 20(3):224-7. PubMed ID: 19226340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.